Skip to main content
Top
Published in: Medical Oncology 4/2009

01-12-2009 | Original Paper

Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure

Authors: Zhiyi Chen, Kun Liang, Jianhua Liu, Mingxing Xie, Xinfang Wang, Qing Lü, Jing Zhang, Lingyun Fang

Published in: Medical Oncology | Issue 4/2009

Login to get access

Abstract

Ultrasound-mediated microbubble destruction (sonoporation) is an efficient and safe nonviral technique for gene delivery. In the present work, we hypothesized that short hairpin RNA (shRNA) interference therapy targeting human Survivin gene could be transfected by the novel combination of ultrasound exposure (USE) and liposome microbubbles (LM). ShRNA vectors targeting Survivin were constructed and transfected under USE and LM conditions. The optimal transfection efficiency and cell injury were compared with those of polyethylenimine (PEI)-mediated transfection in different cancer cell lines (HeLa, HepG2, Ishikawa, MCF-7, and B16-F10). The effects of gene downregulation and cell apoptosis were further investigated. The results indicated that P + USE + LM group could significantly increase the gene expression as compared with plasmid group, plasmid + USE group, plasmid + LM group (< 0.001). The transfection efficiency of the novel combination was nearly equal to PEI-mediated transfection in some cancer cell lines while the cell viability did not decrease markedly. Reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis also confirmed that Survivin mRNA and protein expression could be knocked down significantly by shRNA transfection under USE and LM condition (< 0.001). This is the first study to verify the role of shRNA therapy in vitro with novel combination of USE and LM. We concluded that this nonviral technique would be valuable in the gene transfection of shRNA and Survivin gene downregulation would lead to apparent cell apoptosis.
Literature
2.
go back to reference Yoon CS, Jung HS, Kim TK, et al. Comparison of the efficiency and toxicity of sonoporation with branched polyethylenimine-mediated gene transfection in various cultured cell lines. J Drug Target. 2008;16(10):773–9. doi:10.1080/10611860802470549.CrossRefPubMed Yoon CS, Jung HS, Kim TK, et al. Comparison of the efficiency and toxicity of sonoporation with branched polyethylenimine-mediated gene transfection in various cultured cell lines. J Drug Target. 2008;16(10):773–9. doi:10.​1080/​1061186080247054​9.CrossRefPubMed
7.
10.
go back to reference Larina IV, Evers BM, Esenaliev RO. Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res. 2005;25(1A):149–56.PubMed Larina IV, Evers BM, Esenaliev RO. Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res. 2005;25(1A):149–56.PubMed
18.
23.
go back to reference Chen ZY, Xie MX, Wang XF, Lü Q, Ding SW. Effects of lipid shell microbubble on ultrasound mediated EGFP gene delivery to transplanted tumors: initial experience. Chinese-German J Clin Oncol. 2008;7(7):424–8. doi:10.1007/s10330-008-0058-3.CrossRef Chen ZY, Xie MX, Wang XF, Lü Q, Ding SW. Effects of lipid shell microbubble on ultrasound mediated EGFP gene delivery to transplanted tumors: initial experience. Chinese-German J Clin Oncol. 2008;7(7):424–8. doi:10.​1007/​s10330-008-0058-3.CrossRef
26.
28.
go back to reference Jiang G, Li J, Zeng Z, Xian L. Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma. Cancer Biol Ther. 2006;5(4):435–40.PubMedCrossRef Jiang G, Li J, Zeng Z, Xian L. Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma. Cancer Biol Ther. 2006;5(4):435–40.PubMedCrossRef
30.
go back to reference Bian AN, Gao YH, Tan KB, et al. Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties. World J Gastroenterol. 2004;10(23):3424–7.PubMed Bian AN, Gao YH, Tan KB, et al. Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties. World J Gastroenterol. 2004;10(23):3424–7.PubMed
31.
go back to reference Liu P, Gao YH, Tan KB, Liu Z, Zuo S. Grey scale enhancement of rabbit liver and kidney by intravenous injection of a new lipid-coated ultrasound contrast agent. World J Gastroenterol. 2004;10(16):2369–72.PubMed Liu P, Gao YH, Tan KB, Liu Z, Zuo S. Grey scale enhancement of rabbit liver and kidney by intravenous injection of a new lipid-coated ultrasound contrast agent. World J Gastroenterol. 2004;10(16):2369–72.PubMed
Metadata
Title
Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure
Authors
Zhiyi Chen
Kun Liang
Jianhua Liu
Mingxing Xie
Xinfang Wang
Qing Lü
Jing Zhang
Lingyun Fang
Publication date
01-12-2009
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 4/2009
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9161-0

Other articles of this Issue 4/2009

Medical Oncology 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.